Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Intensity Therapeutics Inc (NASDAQ: INTS) closed the day trading at $0.38 down -4.78% from the previous closing price of $0.4. In other words, the price has decreased by -$4.78 from its previous closing price. On the day, 1.22 million shares were traded. INTS stock price reached its highest trading level at $0.3993 during the session, while it also had its lowest trading level at $0.3785.
Ratios:
For a better understanding of INTS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.60. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INTS now has a Market Capitalization of 22836700 and an Enterprise Value of 15887700.
Stock Price History:
The Beta on a monthly basis for INTS is 4.24, which has changed by -0.8465384 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, INTS has reached a high of $3.18, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is 3.22%, while the 200-Day Moving Average is calculated to be -50.30%.
Shares Statistics:
Over the past 3-months, INTS traded about 30.26M shares per day on average, while over the past 10 days, INTS traded about 1704940 shares per day. A total of 60.06M shares are outstanding, with a floating share count of 53.63M. Insiders hold about 10.72% of the company’s shares, while institutions hold 4.93% stake in the company. Shares short for INTS as of 1763078400 were 3588277 with a Short Ratio of 0.12, compared to 1760486400 on 2253998. Therefore, it implies a Short% of Shares Outstanding of 3588277 and a Short% of Float of 6.1899999999999995.
Earnings Estimates
The company has 3.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.32 and -$0.37 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.22, with 2.0 analysts recommending between -$0.19 and -$0.25.
